The different molecular subtypes of breast cancer (HER2-positive (HER2pos), hormone receptor-positive (HRpos; containing Luminal A-like and Luminal B-like breast cancer) and triple negative breast cancer (TNBC)) exhibit profound intrinsic differences. This evidence concerns the gene ERBB2 and breast carcinoma.